-transparent.png){kind=logo}
The abuse liability of alprazolam was studied in 17 abstinent alcoholic and 12 control subjects. A single 1-mg oral dose of alprazolam was administered, and subjective effects were measured by scales modified from the Addiction Research Center Inventory (ARCI). Multiple blood samples for alprazolam measurement were drawn over 48 hours. No statistically significant differences in pharmacokinetic parameters were found between groups. Alcoholics had lower baseline scores on the ARCI-Morphine/Benzedrine Group Scale (euphoria) and had greater drug-induced changes than nonalcoholics. The findings suggest that alcoholics may be at high risk to abuse alprazolam because it has a positive mood effect not seen in nonalcoholics.
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
March 1995,
Clinical pharmacology and therapeutics,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
January 1984,
Journal of clinical pharmacology,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
July 1996,
The American journal of psychiatry,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
April 1995,
Journal of clinical psychopharmacology,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
April 1994,
Clinical pharmacology and therapeutics,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
November 1994,
The Journal of pharmacology and experimental therapeutics,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
May 1988,
The International journal of the addictions,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
June 1993,
Clinical pharmacokinetics,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
January 1993,
Neuroscience and biobehavioral reviews,
D A Ciraulo, and
J G Barnhill, and
D J Greenblatt, and
R I Shader, and
A M Ciraulo, and
M F Tarmey, and
M A Molloy, and
M E Foti
January 1982,
Pharmacotherapy,
